Atlas Trials

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors

Clinical trial NCT05768945 · COMPLETED

Trial details

NCT number
NCT05768945
Sponsor
Brigham and Women's Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Diabetes
Start date
2022-11-30
Primary completion
2023-07-07
Enrollment
742670

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.